Biotech hit by credit crunch
As stock markets turn their backs on the high-risk sectors, France Biotech’s annual survey reveals the depths to which investment has fallen.
Biotech entrepreneur becomes UK Science Minister
Who can deliver on science and innovation? I can, says the UK’s new Science Minister, Paul Drayson.
Intrapreneurialism: innovation in large organisations – a do or die proposition
A team of highly creative intrapreneurs is key to the growth of large corporations, an MIT conference hears.
The credit crunch: start-ups can’t get bank loans, but can VCs and angels help?
Who’s going to rescue the lab with a smart, invention, or a start-up looking for second-stage financing?
Unravelling the labyrinth: Commission sets out common strategy for R&D
Member states should identify priority areas where Europe can compete globally, says the Commission.
Are you a subscriber? A lead or a deal to announce?
Just tell us about it. Click here for our easy subscriber-access form
INFORMATION MARKETPLACEThe community site for views & news
Why on earth doesn’t Europe have its own BIO?
Europe’s biotechnology industry needs to speak with one voice and have a single, flagship gathering like the US’s annual BIO conference, says Eric Poincelet.
Panic, revulsion and American innovation
What’s left to like in the US enterprise system? Plenty, for universities and technology entrepreneurs, says Science|Business Editor Richard L. Hudson.
Whither Intellectual Property?
As patent offices choke on the surge in demand, and illegal downloading and counterfeiting grows apace, Francis Gurry, new head of WIPO, outlines his priorities.
Free to all users
Subscribers only
S|B lead stories RSS
